| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Honore Tage | Director | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON | /s/ Tage Honore | 24 Feb 2026 | 0001967946 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VNDA | Common Stock | Sale | $240,900 | -30,000 | -24% | $8.03 | 93,469 | 23 Feb 2026 | Direct |